This website uses cookies for usage measurement and traffic analysis purposes.
By clicking the "Agree" button or continuing to browse this site, you consent to the use of cookies.
For more details, please refer to the Privacy Policy
(opens in a new window).
| Department | Department of Medical Oncology |
|---|
Kan Yomemori, PhD., MD. is the director of Department of Medical Oncology from 2020 and co-staff physician of the department of Experimental Therapeutics (Phase I unit) at the National Cancer Center Hospital, Tokyo, Japan. Dr Kan Yonemori had medical reviewer experience in the Pharmaceuticals and Medical Devices Agency and the visiting researcher in the US National Cancer Institute and the Food and Drug Administration. Dr Kan Yonemori is one of expert medical oncologists for breast cancer, gynecological cancer, germ cell tumor, sarcoma and other miscellaneous rare cancers. Dr Yonemori is one of lead Principle Investigators in the National Cancer Center Hospital, Tokyo and he lead the field of oncology drug development scene including phase I trial to phase II/III trials for various cancers.
Medical Oncology, Drug development, Reguraltory science and International collaboration.
| 2021-present | Director, Department of Medical Oncology, National Cancer Center Hospital |
|---|---|
| 2020-2021 | Director, Department of Breast and Medical Oncology, National Cancer Center Hospital |
| 2015-2020 | Hospital Ward Chief Physician, Department of Breast and Medical Oncology, National Cancer Center Hospital |
| 2013-2015 | Chief Physician, Department of Breast and Medical Oncology, National Cancer Center Hospital |
| 2010-2013 | Staff Physician, Department of Breast and Medical Oncology, National Cancer Center Hospital |
